SPIRAMYCINE METRONIDAZOLE ZENTIVA 1.5 MUI/250 mg, film-coated tablet 10 tablets
Active ingredients: Metronidazole, Spiramycin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIRAMYCINE METRONIDAZOLE ZENTIVA 1,5 MUI/250 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 10 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Sept 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62319930CIP73554727CIP133400935547279Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPIRAMYCINEcomprimé | 1 500 000 UI · un comprimé | SA |
| MÉTRONIDAZOLEcomprimé | 250 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.